Amid travel fears that students receiving Covaxin may not be allowed in many countries as the vaccine is not listed, Hyderabad-based pharma major Bharat Biotech on Tuesday said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary
